Osteosynthesis with anatomic reduction after malleolar fractures improves ten years outcome: a single center trial
European Journal of Orthopaedic Surgery & Traumatology · 2024
DOI: 10.1007/s00590-024-04153-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Orthopaedic Surgery & Traumatology, 2024. Verfasst von Amal Chidda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery and Traumatology, Fribourg Cantonal Hospital, University of Fribourg, Chemin Des Pensionnats 2-6, 1708, Fribourg, S…. Hauptthemen laut MEDLINE: Ankle Fractures, Fracture Fixation, Internal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grant HFR, University of Fribourg.
Abstract (Originalsprache)
Introduction
Malleolar fractures are the most common ankle fractures and a major risk factor for ankle osteoarthritis in the long-term. Little is known about modifiable risk factors for a satisfactory outcome. This study aimed to assess the long-term clinical, functional and radiological outcomes in patients after osteosynthesis.
Methods
In this retrospective single center study, we assessed the difference in patients who underwent surgical intervention for malleolar fractures sustained between 2007 and 2014. The reduction was assessed on the first postoperative radiograph. At follow-up patients completed a questionnaire, including the European Foot and Ankle Society (EFAS) and Short Form-12 (SF-12) scores to evaluate patient-reported outcomes and quality of life. Ankle osteoarthritis was assessed using the Kellgren and Lawrence classification.
Results
One hundred seventeen patients, 102 with anatomic reduction and 15 with malreduction, were reached at mean follow-up at 11.4 years and 10.9 years. The mean EFAS score was 18,0 for anatomic and 16,1 for nonanatomic reduction and 6.1 and 4.5 for the sport component. The rate of satisfaction with the result was 8.2 in anatomic reduction and 7.5 in the malreduction. There was no significant difference in the SF-12 group between the two groups. Anatomic reduction is a protective facture for a satisfactory outcome in the univariate model with the hazard ratio of 5.94.
Conclusion
Anatomic reduction is one of the strongest protective factors for satisfactory outcome after malleolar fractures in a follow-up of more than 10 years.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery and Traumatology, Fribourg Cantonal Hospital, University of Fribourg, Chemin Des Pensionnats 2-6, 1708, Fribourg, Switzerland.
- Department of Orthopaedic Surgery and Traumatology, Valais Hospital, Martiny, Switzerland.
- Department of Orthopaedic Surgery and Traumatology, Inselspital, University of Bern, Bern, Switzerland.
- Department of Orthopaedic Surgery and Traumatology, Fribourg Cantonal Hospital, University of Fribourg, Chemin Des Pensionnats 2-6, 1708, Fribourg, Switzerland. angela.seidel@h-fr.ch.
Förderung
- Grant HFR
- University of Fribourg
Zitieren
APA
Chidda, A., Soares, S., Nogueira, P., Schwab, J. M., Tannast, M., & Seidel, A. (2024). Osteosynthesis with anatomic reduction after malleolar fractures improves ten years outcome: a single center trial. European Journal of Orthopaedic Surgery & Traumatology. https://doi.org/10.1007/s00590-024-04153-9
Vancouver
Chidda A, Soares S, Nogueira P, Schwab JM, Tannast M, Seidel A. Osteosynthesis with anatomic reduction after malleolar fractures improves ten years outcome: a single center trial. European Journal of Orthopaedic Surgery & Traumatology. 2024. doi:10.1007/s00590-024-04153-9
BibTeX
@article{Chidda2024,
author = {Chidda, Amal and Soares, Sérgio and Nogueira, Pedro and Schwab, Joseph M and Tannast, Moritz and Seidel, Angela},
title = {Osteosynthesis with anatomic reduction after malleolar fractures improves ten years outcome: a single center trial},
journal = {European Journal of Orthopaedic Surgery & Traumatology},
year = {2024},
doi = {10.1007/s00590-024-04153-9}
}
EUVIMED